214697-26-4

ABT 702 Dihydrochloride is employed in the assay for quantitative high-?throughput screening of anti-?hepatitis C virus compounds.

Potent non-nucleoside adenosine kinase inhibitor (IC 50 = 1.7 nM), selective over other sites of adenosine interaction (A 1 , A 2A and A 3 receptors, adenosine transporter and adenosine deaminase). Displays oral activity in animal models of pain and inflammation.